Anxiety Disorders

Question 1

Symptoms of specific phobia must last at least this long, according to the DSM-5 criteria

Answer 1

6 months

Question 2

What is the first line treatment for specific phobia?

Answer 2

Cognitive behavioral therapy / psychotherapy

Question 3

Are males or females more likely to have generalized anxiety disorder?

Answer 3

Females (2x as common)

Question 4

People of this descent are more likely to have generalized anxiety disorder

Answer 4

European

Question 5

DSM-5 criteria for generalized anxiety disorder is that it must occur for at least this long

Answer 5

6 months

Question 6

Is generalized anxiety disorder related to a single trigger?

Answer 6

No

Question 7

The DSM-5 criteria for this condition is that it must be associated with three or more of the following:
Restlessness or feeling keyed up or on edge
Being easily fatigued
Difficulty concentrating or mind going blank
Irritability
Muscle tension
Sleep disturbance

Answer 7

Generalized anxiety disorder

Question 8

What is the most effective treatment for generalized anxiety disorder?

Answer 8

Psychotherapy

Question 9

When is pharmacotherapy used for generalized anxiety disorder?

Answer 9

When GAD is serious enough to produce functional disability

Question 10

What is the difference between generalized anxiety disorder and adjustment disorder in regards to how long it lasts?

Answer 10

GAD lasts 6+ months
Adjustment disorder develops within 3 months of known stressor (resolves within 6 months)

Question 11

What are the first line drugs for generalized anxiety disorder?

Answer 11

SSRIs and SNRIs
(e.g. duloxetine)

Question 12

Benzodiazepines target GABA-A receptor, which has this effect on chloride channels

Answer 12

Increases frequency of chloride channel opening

Question 13

Is diazepam short or long acting?

Answer 13

Long acting
(half life 30-100 hours)

Question 14

Are benzodiazepines used for generalized anxiety disorder?

Answer 14

Are second line drugs - largely replaced by antidepressants for anxiety

Question 15

Paradoxical excitement (mostly in children and elderly) can occur as a side effect of this type of drug which is a second line therapy for generalized anxiety

Answer 15

Benzodiazepines

Question 16

Buspirone is a partial agonist of this receptor

Answer 16

5-HT1A

Question 17

This second line drug for generalized anxiety disorder is a partial agonist of the 5-HT1A receptor

Answer 17

Buspirone

Question 18

Is there misuse potential with Buspirone?

Answer 18

No
Will not affect cognitive or psychomotor function
(contrast to benzos)

Question 19

Buspirone interacts with this type of drug, and can cause elevated BP and serotonin syndrome

Answer 19

MAOIs

Question 20

Buspirone is a second line therapy for this disorder

Answer 20

Generalized anxiety disorder

Question 21

Hydroxyzine is a second line therapy for this disorder

Answer 21

Generalized anxiety disorder

Question 22

Condition characterized by series of unexpected/spontaneous panic attacks involving intense, terrifying fear
Generally followed by period of fear for another panic attack

Answer 22

Panic disorder

Question 23

DSM-5 criteria of this condition requires four or more of the following symptoms:
Palpitations, pounding heart, or accelerated heart rate
Sweating
Trembling or shaking
Sensations of shortness of breath or smothering
Feelings of choking
Chest pain or discomfort
Nausea or abdominal distress
Feeling dizzy, unsteady, lightheaded, or faint
Chills or heat sensations
Paresthesias
Derealization or depersonalization
Fear of losing control or “going crazy”
Fear of dying

Answer 23

Panic disorder

Question 24

Complications of this type of anxiety disorder include increased risk of alcohol use disorder, depression, suicide attempts, and excessive use and dependence on healthcare services and resources

Answer 24

Panic disorder

Question 25

What is the first line pharmacotherapy for Panic disorder?

Answer 25

SSRIs > Venlafaxine

Question 26

DSM-5 criteria of this condition includes - A marked fear or anxiety about two or more of the following situations: Using public transportation, Being in open spaces, Being in enclosed spaces, Standing in line or being in a crowd, Being outside the home alone - The situations are avoided or else are endured with marked distress or anxiety - The fear, anxiety, or avoidance is persistent, typically lasting 6 months or more

Answer 26

Agoraphobia

Question 27

DSM-5 criteria for Agoraphobia states it must last at least this long

Answer 27

6 months

Question 28

What are the two types of social anxiety disorder?

Answer 28

Generalized (Fear and avoidance extend to a wide range of social situations) Non-generalized (Fear and avoidance is limited to one or two situations)

Question 29

What is the first line pharmacotherapy for social anxiety disorder?

Answer 29

SSRIs > SNRIs

Question 30

DSM-5 criteria for PTSD can include experiencing repeated or extreme exposure to aversive details of the traumatic event, but this criterion does not apply to exposure through electronic media unless this exposure is related to this

Answer 30

Work

Question 31

DSM-5 criteria for PTSD is that the duration of the disturbance is more than this duration

Answer 31

1 month

Question 32

What is the first line pharmacotherapy for PTSD?

Answer 32

SSRIs

Question 33

What is the second line pharmacotherapy for PTSD?

Answer 33

SNRIs

Question 34

This type of drugs is considered low second line pharmacotherapy for PTSD

Answer 34

Tricyclics

Question 35

DSM-5 criteria for adjustment disorder states that the symptoms do not persist for more than this duration after the stressor has terminated

Answer 35

6 months

Question 36

This type of anxiety disorder may be a PANDAS (Pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections)

Answer 36

Obsessive compulsive disorder

Question 37

What is the first line pharmacotherapy for OCD?

Answer 37

SSRIs

Question 38

What is the second line pharmacotherapy for OCD?

Answer 38

SNRI/Clomipramine

Question 39

Can body dysmorphic disorder be explained by an eating disorder?

Answer 39

No

Question 40

DSM-5 criteria of this condition includes: - One or more somatic symptoms - Excessive thoughts, feelings, or behaviors related to the somatic symptoms as manifested by at least one of the following: Disproportionate and persistent thoughts about the seriousness of one’s symptoms Persistently high level of anxiety about health or symptoms Excessive time and energy devoted to these symptoms or health concerns

Answer 40

Somatic symptom disorder

Question 41

Type of anxiety disorder characterized by: Preoccupation with having or acquiring a serious illness Somatic symptoms are not present or are only mild in intensity There is a high level of anxiety about health The individual performs excessive health-related behaviors or exhibits maladaptive avoidance

Answer 41

Illness anxiety disorder

Question 42

Condition characterized by the intentional production of signs and symptoms of medical or mental disorder with misrepresentation of history of symptoms motivated by psychological (internal) gain

Answer 42

Factitious disorder

Question 43

Type of anxiety disorder characterized by: One or more symptoms of altered voluntary motor or sensory function Clinical findings are incompatible with symptoms and cannot be explained by another disorder Recovery is often spontaneous Symptoms are significant but patient ‘worry’ level may be low or absent

Answer 43

Conversion disorder (functional neurological symptom disorder)